OncLive Staff

Articles

The OncFive: Top Oncology Articles for the Week of 9/29

October 5th 2024

Perioperative nivolumab receives FDA approval for resectable NSCLC, acalabrutinib sNDA gets priority review for MCL, and more from OncLive this week.

The OncFive: Top Oncology Articles for the Week 9/22

September 28th 2024

The FDA’s ODAC votes against the risk:benefit profile of frontline PD-1 inhibitors in select tumor types, osimertinib gains approval for select NSCLC, and more this week from OncLive.

The OncFive: Top Oncology Articles for the Week of 9/15

September 21st 2024

Adjuvant ribociclib receives FDA approval for HR+ breast cancer, AMG 193 elicits responses in MTAP-deleted solid tumors, and more this week from OncLive.

2024 ESMO Congress Preview for Medical Oncologists: The Show and After Show

September 10th 2024

OncLive co-hosts Kristie L. Kahl and Andrew Svonavec highlight abstracts for medical oncologists to look out for at the upcoming ESMO Congress in Barcelona, with some additional tidbits to round out the main event.

The OncFive: Top Oncology Articles for the Week of 9/1

September 7th 2024

This list features a snapshot of key August FDA oncology decisions, efforts to integrate health equity into guideline development, and more.

The OncFive: Top Oncology Articles for the Week of 8/25

August 31st 2024

Mirdametinib NDA gets priority review in NF1-associated plexiform neurofibromas, experts explore social media's evolving role in cancer care, and more.

The OncFive: Top Oncology Articles for the Week of 8/18

August 24th 2024

A frontline doublet receives FDA approval in EGFR+ NSCLC, a CRL is issued to linvoseltamab in multiple myeloma, and more this week from OncLive.

OncLive Honors 15 Cancer Care Pioneers

July 2nd 2024

OncLive honors 15 oncology leaders with the 2024 Giants of Cancer Care awards for their innovations in improving patient outcomes.

2024 ASCO Annual Meeting Preview: The Show and After Show

May 22nd 2024

OncLive co-hosts Kristie L. Kahl and Andrew Svonavec highlight abstracts to look out for at the upcoming ASCO Annual Meeting in Chicago, with some additional tidbits to round out the main event.

Gulhati Details Treatments and Advances in Pancreatic Cancer

May 2nd 2024

Prateek Gulhati, MD, PhD, delivers takeaways from his presentation at the 2022 Annual Oncology Clinical Practice and Research Summit and key trials in pancreatic cancer that have moved the field forward.

Husband and Wife Duo Pursue Medicine Together

May 2nd 2024

Manmeet Singh Ahluwalia, MD, and his wife, Harneet Kaur Walia, MD, say that they learn from each other’s experiences and share in successes.

Investigators Highlight Improvements in Immune and Endocrine Therapies for Breast Cancer

May 2nd 2024

Breast oncologists recap findings from the 2022 San Antonio Breast Cancer Symposium.

Dr Kyriakopoulos on the Investigation of Masofaniten Plus Enzalutamide in mCRPC

March 7th 2024

Dr Kyriakopoulos sheds light on the potential synergy between masofaniten and enzalutamide when used in combination for patients with prostate cancer.

Camidge and Farmen Discuss the Nuances of Cancer Care and Patient Advocacy

March 4th 2024

Camidge and Farmen talk through patient advocacy, Farmen’s cancer diagnosis, and the people who rallied around Farmen during the early days of her disease.

Kang Highlights Considerations for the Integration of Toripalimab into Nasopharyngeal Carcinoma Clinical Practice

February 29th 2024

Dr Kang discusses the significance of the FDA approval of toripalimab for nasopharyngeal carcinoma and his anticipated use of the agent.

Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS

February 26th 2024

Dr Mims discusses the utility of emavusertib in acute myeloid leukemia and myelodysplastic syndrome and the rationale for the TakeAim Leukemia trial.

Tripathy Talks Through the Enduring Impact of the Miami Breast Cancer Conference

February 22nd 2024

Dr Tripathy discusses the unique aspects of the Miami Breast Cancer Conference that make it worth returning to year after year.

Kitko and Patel Emphasize the Importance of GVHD Research and Awareness

February 19th 2024

Drs Kitko and Patel discuss graft-versus-host disease recognition, treatment selection, and ongoing research with novel agents and biomarkers of response.

Camidge and Kelley Share the Details of Practicing Within Various Health Care Models

February 15th 2024

Drs Camidge and Kelley discuss the ways Dr Kelley’s passion for research guided his early career path.

FDA Approval Insights: Enfortumab Vedotin Plus Pembrolizumab in Locally Advanced/Metastatic Urothelial Carcinoma

February 12th 2024

Dr Galsky discusses the FDA approval of enfortumab vedotin plus pembrolizumab for patients with locally advanced or metastatic urothelial cancer.